AI Assistant
Blog
Pricing
Log In
Sign Up
Reduced relative dose intensity of primary chemotherapy does not influence prognosis of patients with Hodgkin lymphoma
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.